Topical Vancomycin for Neurosurgery Wound Prophylaxis

PHASE3UnknownINTERVENTIONAL
Enrollment

1,103

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

November 30, 2019

Study Completion Date

June 30, 2021

Conditions
InfectionSurgeryNervous System Diseases
Interventions
DRUG

Vancomycin

Topically applied powder and paste to surgical site at time of closure.

Trial Locations (1)

10032

Columbia University Medical Center, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Agency for Healthcare Research and Quality (AHRQ)

FED

collaborator

Cornell University

OTHER

collaborator

Icahn School of Medicine at Mount Sinai

OTHER

lead

Columbia University

OTHER